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Objectives We examined the predictive power of erectile dysfunction (ED) on coronary heart disease (CHD) events in Chi-
nese men with type 2 diabetes.
Background Subjects with diabetes are prone to develop cardiovascular complications. Erectile dysfunction is strongly associ-
ated with CHD in cross-sectional studies, but prospective data are lacking.
Methods A consecutive cohort of men with no clinical evidence of cardiovascular disease underwent comprehensive as-
sessments for diabetic complications. Erectile dysfunction was defined according to the definition of the Na-
tional Institutes of Health Consensus Conference 1992. Coronary heart disease events were censored with cen-
tralized territory-wide hospital databases in 2005.
Results Of 2,306 subjects (age: 54.2  12.7 years; follow-up: 4.0 [range 1.7 to 7.1] years), 26.7% had ED at baseline.
The incidence of CHD events was higher in men with ED than those without (19.7/1,000 person-years, 95% con-
fidence interval [CI] 14.3 to 25.2 person-years vs. 9.5/1,000 person-years, 95% CI 7.4 to 11.7 person-years).
Men who developed CHD events were older; had a higher frequency of ED and microvascular complications; had
longer duration of diabetes; and had higher blood pressure, total cholesterol, low-density lipoprotein cholesterol,
and urinary albumin/creatinine ratio but lower high-density lipoprotein cholesterol and estimated glomerular
filtration rate than those without CHD events. Erectile dysfunction remained an independent predictor for CHD
events (hazard ratio 1.58, 95% CI 1.08 to 2.30, p  0.018) after adjustment for other covariates along with age,
duration of disease, and use of antihypertensive agents and albuminuria.
Conclusions In type 2 diabetic men without clinically overt cardiovascular disease, the presence of ED predicts a new onset
of CHD events. Symptoms of ED should be independently sought to identify high-risk subjects for comprehensive
cardiovascular assessments. (J Am Coll Cardiol 2008;51:2045–50) © 2008 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.02.051a
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Cen with diabetes have a higher prevalence of erectile dys-
unction (ED) compared with the general population. In these
ubjects, the prevalence of ED increases with age and duration
nd severity of disease (1,2). Studies in different populations
ave reported frequencies of ED ranging from 20% to 90%,
epending on choice of assessment methods (3–6).
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ong Kong Foundation for Research and Development in Diabetes, established
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gree to the article as written.e
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008, accepted February 5, 2008.Recent studies suggest close associations between ED and
therosclerosis, and ED might serve as a clinical marker for
oronary, peripheral, or cerebrovascular diseases (7–12). In
ross-sectional studies, strong associations between calcu-
ated Framingham coronary risk score and ED have been
eported (11,13,14). However, to date, the prognostic value
f ED in predicting adverse cardiovascular events such as
oronary heart disease (CHD) has not been confirmed in
rospective analyses.
See page 2051
In the present study, we examined the impact of ED on
he incidence of CHD events in a prospective cohort of
hinese type 2 diabetic men who did not have clinicalvidence of cardiovascular diseases at baseline.
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Patients and methods. Patients
with diabetes were referred from
general practitioners and general
medical and specialist hospital
clinics to the Prince of Wales
Hospital Diabetes Centre for com-
prehensive assessment of complica-
tions and risk factors based on
the European DIABCARE pro-
tocol (15). Between 1995 and
2005, 3,640 men were assessed.
Patients with type 1 diabetes
(n  174) defined as acute pre-
sentation with diabetic ketoaci-
dosis, heavy ketonuria (3), or
continuous requirement of insu-
lin within 1 year of diagnosis
were excluded from this analysis.
Patients with clinically evident
cardiovascular diseases, including
CHD, stroke, or peripheral arte-
rial disease (PAD), at baseline
ere not included (n  548). Information on ED by
uestionnaire was not available in 612 patients. Hence,
,306 patients were included in the final analysis. Informed
onsent was obtained from all patients at the time of
ssessment to allow use of data for research purpose. The
tudy was approved by the Chinese University of Hong
ong Clinical Research Ethics Committee.
Details of clinical assessments and laboratory assays were
escribed previously (16). Presence of CHD-related events
as defined as a past history of myocardial infarction,
ospital admissions with heart failure, revascularization, or
hest pain with abnormal electrocardiogram or stress test.
resence of stroke was defined as admission with typical
eurological symptoms with or without recovery and con-
rmed on imaging. Peripheral arterial disease was defined as
bsent pedal pulses confirmed by ankle-brachial ratio 0.9
n Doppler ultrasound examination or a history of previous
evascularization procedures. None of the patients in this
onsecutive cohort had a history of stroke, CHD, or PAD.
or all study participants, the use of antihypertensive
edications, lipid-lowering agents, and angiotensin-
onverting enzyme inhibitors (ACEIs)/angiotensin receptor
lockers (ARBs) at baseline was also recorded. Antihyper-
ensive medications included all classes of drugs that are
ndicated for hypertension, other than ACEI/ARB. The use
f lipid-lowering drugs included statins and fibrates.
Patients were asked directly whether they suffered from
D according to the definition of the National Institutes of
ealth (NIH) Consensus Conference 1992 (17). Erectile
ysfunction was defined as the inability to attain and/or
aintain penile erection sufficient for satisfactory sexual
Abbreviations
and Acronyms
ACEI  angiotensin-
converting enzyme inhibitor
ACR  albumin/creatinine
ratio
ARB  angiotensin
receptor blocker
CHD  coronary heart
disease
CI  confidence interval
DBP  diastolic blood
pressure
ED  erectile dysfunction
eGFR  estimated
glomerular filtration rate
IIEF  International Index
of Erectile Function
PAD  peripheral arterial
disease
SBP  systolic blood
pressureerformance. The response to the question was either “Yes” ur “No.” All patients had at least 2 urinary collections: a
terile, random spot urine sample was used to measure
lbumin/creatinine ratio (ACR) followed by a timed collec-
ion (4- or 24-h) for measurement of urinary albumin
xcretion rate. The definition of albuminuria was based on
he mean value of ACR from both the timed and spot
rinary samples. Normoalbuminuria was defined as a mean
CR 3.5 mg/mmol, microalbuminuria, 3.5 to 25 mg/
mol, and macroalbuminuria,25 mg/mmol (18). Sensory
europathy was defined as 2 of 3 abnormal signs or
ymptoms: numbness in lower limbs or reduced sensation
ith either monofilament or graduated tuning fork. Esti-
ated glomerular filtration rate (eGFR; expressed in ml/
in/1.73 m2) was calculated with the abbreviated Modifi-
ation of Diet in Renal Disease (MDRD) formula further
djusted for the Chinese ethnicity (19):
FR 186 SCR 0.0111.154  age0.203
 0.742 if female 1.233 if Chinese
here SCR is serum creatinine expressed as mol/l and
.233 is the adjusting coefficient for Chinese. Chronic
idney disease (CKD) was defined by eGFR 60 ml/min/
.73 m2 (20).
linical outcomes. Hong Kong has a heavily subsidized
ealth care system, and 95% of inpatient and chronic care
re provided by public hospitals managed by the Hospital
uthority. All clinical end points including hospital admis-
ions and mortality were censored on July 30, 2005 with
atabases from the Hospital Authority Central Computer
ystem, which records admissions to all public hospitals.
hese databases, including the Hong Kong Death Registry,
ere matched by a unique identification number, the Hong
ong Identity Card number, which is compulsory for all
esidents in Hong Kong and used by all government
epartments and major organizations. With the Interna-
ional Classification of Diseases-9th Revision code, hard
HD events were defined as: 1) acute myocardial infarction
code 410) or death due to coronary cause (code 410, 411 to
14, 428); or 2) other nonfatal CHD (code 411 to 414,
rocedure codes 36 and 00.66).
tatistical analysis. The analysis was performed with the
tatistical Package for Social Sciences (version 11.5, SPSS
nc., Chicago, Illinois) package. Triglyceride and ACR were
ogarithmically transformed, owing to skewed distributions.
ll data are expressed as mean  SD or median [interquar-
ile range], as appropriate. The Student t test or analysis of
ariance was used for between-group comparisons for con-
inuous variables, and the chi-square test was used for
ategorical variables. Logistic regression analysis was per-
ormed to identify factors associated with ED. Cox propor-
ional hazards regression analysis was used to estimate the
azard ratio with 95% confidence interval (CI) for CHD
vents. Univariate analysis was performed with variables
ncluding ED; age; duration of diabetes; smoking history;
se of antihypertensive, ACEI/ARB, or lipid-lowering
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May 27, 2008:2045–50 Erectile Dysfunction and CHD in Diabetesedications; glycosylated hemoglobin (HbA1c); fasting
lasma glucose; baseline status of retinopathy, sensory
europathy, and ACR; eGFR; body mass index; waist
ircumference; systolic blood pressure (SBP) and diastolic
lood pressure (DBP); low-density lipoprotein cholesterol;
igh-density lipoprotein cholesterol; and triglycerides. Fac-
ors associated with CHD (p  0.1) on univariate analysis
ere included in the multivariate analysis. A forward step-
ise algorithm (p  0.10 for entry, and p  0.05 for stay)
as used. A p value  0.05 (2-tailed) was considered to be
ignificant.
esults
n this cohort of 2,306 subjects (mean age 54.2  12.7
ears) with a median follow-up period of 4.0 years (inter-
uartile range 1.7 to 7.1), 616 (26.7%) had ED according to
he NIH definition. There was no difference in clinical and
iochemical parameters between the 612 in whom informa-
ion on ED was not available and the remainder (data not
hown). Men with ED were older and had a longer duration
f diabetes and higher SBP, high-density lipoprotein cho-
esterol, serum creatinine, and ACR but lower eGFR and
ody mass index than those without ED. They also had
igher rates of retinopathy, sensory neuropathy, albumin-
ria, and chronic kidney disease and were more frequently
sing antihypertensive medications or lipid-lowering agents
r taking ACEIs/ARBs (Table 1). After adjusting for other
onfounding factors on logistic regression modeling, ED at
aseline was associated with age (odds ratio [95% CI] 1.03
1.02 to 1.04], p  0.001), body mass index (0.96 [0.93 to
.99], p  0.007), retinopathy (1.91 [1.52 to 2.39], p 
.001), sensory neuropathy (1.65 [1.32 to 2.07], p 0.001),
se of antihypertensive medications (1.35 [1.07 to 1.71],
 0.013), and use of ACEI/ARB (1.50 [1.16 to 1.93],
 0.002).
Although there was no clinical evidence of cardiovascular
isease at baseline, new CHD events occurred in 123 (5.3%)
ubjects during the 4-year observational period, giving an
nnualized incidence of 12.0/1,000 person-years (95% CI
.90 to 14.1). In men with ED, the incidence was 19.7/
,000 person-years (95% CI 14.3 to 25.2) compared with
.5 (95% CI 7.4 to 11.7) in those without ED. Men who
eveloped new CHD events were older and had a longer
uration of diabetes, higher SBP and DBP, total choles-
erol, low-density lipoprotein cholesterol, and urinary ACR
ut lower high-density lipoprotein cholesterol and eGFR.
hese subjects also had higher frequencies of retinopathy,
lbuminuria, use of antihypertensive medications, and ED
t baseline (Table 2).
On univariate Cox regression analysis, age (hazard ratio
95% CI] 1.04 [1.02 to 1.05], p  0.001), duration of
iabetes (1.06 [1.04 to 1.09], p  0.001), SBP (1.02 [1.01
o 1.03], p  0.001), albuminuria (3.42 [2.24 to 5.23], p 
.001), retinopathy at baseline (2.38 [1.66 to 3.41], p 
.001), eGFR (0.99 [0.98 to 0.99], p  0.001), use of cipid-lowering agents (1.77 [1.01 to 3.11], p  0.047), use
f antihypertensive medications (2.34 [1.62 to 3.37], p 
.001), use of ACEI/ARB (2.15 [1.40 to 3.30], p  0.001),
nd ED (2.23 [1.55 to 3.20], p  0.001) were associated
ith new CHD events. In addition, DBP (1.01 [1.00 to
.03], p  0.09) had borderline statistical significance.
hese factors were entered in a forward stepwise model for
ultivariate analysis to identify independent predictors.
rectile dysfunction remained an independent predictor of
HD events (hazard ratio 1.58 [95% CI 1.08 to 2.30], p 
.018), after adjusting for other confounding factors. Other
ndependent factors were age, duration of diabetes, use of
ntihypertensive medications, and baseline status of mac-
oalbuminuria (Table 3). The Kaplan-Meier curves for
HD events in subjects stratified by ED separated early and
linical and Metabolic Characteristics of 2,306hinese Men With Type 2 Diab tes Stratified by theres nce of Er ctile Dysfunction
Table 1
Clinical and Metabolic Characteristics of 2,306
Chinese Men With Type 2 Diabetes Stratified by the
Presence of Erectile Dysfunction
Erectile Dysfunction
No Yes p Value
n (%) 1,690 (73.3) 616 (26.7)
Age (yrs) 52.4 13.0 59.0 10.5 0.001
Duration of diabetes (yrs) 5.3 5.9 7.6 6.5 0.001
Waist (cm) 88.3 9.7 87.9 9.7 0.399
SBP (mm Hg) 132 18 136 20 0.001
DBP (mm Hg) 78 11 77 11 0.450
Body mass index (kg/m2) 25.2 3.9 24.6 3.7 0.001
HbA1c (%) 7.7 1.9 7.9 1.8 0.094
Fasting plasma glucose (mmol/l) 8.6 3.3 8.9 3.5 0.080
Total cholesterol (mmol/l) 5.2 1.2 5.2 1.2 0.645
HDL-cholesterol (mmol/l) 1.2 0.3 1.3 0.3 0.007
LDL-cholesterol (mmol/l) 3.2 1.0 3.1 0.9 0.254
Triglycerides (mmol/l), n (IQR) 1.35 (0.95–2.10) 1.32 (0.91–1.93) 0.252
Serum creatinine
(mol/l), n (IQR)
87 (76–100) 92 (81–110) 0.001
Urine albumin/creatinine ratio
(mg/mmol), n (IQR)
1.4 (0.6–6.1) 2.7 (0.7–18.0) 0.001
eGFR (ml/min/1.73 m2) 89.4 25.4 79.1 25.0 0.001
Smoking (%) 0.020
Never-smoker 47.8 43.2
Ex-smoker 26.6 32.4
Current smoker 25.6 24.4
Retinopathy (%) 19.2 38.5 0.001
Sensory neuropathy (%) 19.8 36.7 0.001
Albuminuria (%) 0.001
Normoalbuminuria 68.1 53.9
Microalbuminuria 21.0 25.1
Macroalbuminuria 10.9 21.0
Chronic kidney disease (%) 5.7 11.7 0.001
Use of antihypertensive
medications (%)
24.5 38.8 0.001
Use of ACEI/ARB (%) 15.6 29.7 0.001
Use of lipid-lowering agents 10.2 14.1 0.01
CEI  angiotensin-converting enzyme inhibitor; ARB  angiotensin receptor blocker; DBP 
iastolic blood pressure; eGFR  estimated glomerular filtration rate; HbA1c  glycosylated
emoglobin; HDL  high-density lipoprotein; IQR  interquartile range; LDL  low-density
ipoprotein; SBP  systolic blood pressure.ontinued to diverge over time (p  0.001) (Fig. 1).
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n this cohort of Chinese men with type 2 diabetes and no
linical evidence of cardiovascular disease, 26% reported
ymptoms of ED. Erectile dysfunction was associated with
ge, disease duration, and presence of other microvascular
omplications. More importantly, men with ED had a
.6-fold increased risk of developing CHD events than
hose without, after adjustment for age, duration of diabe-
es, and other cardiovascular risk factors.
Previous studies have documented that patients with
iabetes are more likely to suffer from ED. In type 1
iabetes, symptoms of ED preceded typical symptoms of
HD by 38.8 months on average (21). Although impo-
ence—a manifestation of ED—is common in type 2 diabetes,
ost studies were retrospective or cross-sectional in nature. In
cross-sectional survey of type 2 diabetic patients, 34%
eported problems of ED (22). Giuliano et al. (1), with the
linical and Metabolic Characteristics of 2,306hinese Men With Type 2 Diab tes Stratified by theres nce of N w Onset of CHD Event
Table 2
Clinical and Metabolic Characteristics of 2,306
Chinese Men With Type 2 Diabetes Stratified by the
Presence of New Onset of CHD Events
CHD Events
No Yes p Value
n (%) 2,184 (94.7) 123 (5.3)
Age (yrs) 53.0 12.8 58.5 11.0 0.001
Duration of diabetes (yrs) 5.8 6.1 8.4 6.4 0.001
Waist (cm) 88.1 9.8 89.0 7.3 0.320
SBP (mm Hg) 133 19 139 19 0.001
DBP (mm Hg) 77 11 80 10 0.004
Body mass index (kg/m2) 25.0 3.9 25.1 3.2 0.701
HbA1c (%) 7.8 1.9 7.9 1.7 0.457
Fasting plasma glucose (mmol/l) 8.7 3.4 9.1 3.5 0.208
Total cholesterol (mmol/l) 5.2 1.2 5.5 1.3 0.002
HDL-cholesterol (mmol/l) 1.24 0.34 1.17 0.30 0.033
LDL-cholesterol (mmol/l) 3.2 1.0 3.5 1.0 0.001
Triglycerides (mmol/l), n (IQR) 1.34 (0.93–2.05) 1.42 (1.01–2.09) 0.592
Serum creatinine
(mol/l), n (IQR)
88 (77–102) 93 (80–112) 0.005
Urine albumin/creatinine ratio
(mg/mmol), n (IQR)
1.5 (0.6–7.7) 4.4 (1.1–48.1) 0.001
eGFR (ml/min/1.73 m2) 107.3 31.6 98.5 32.8 0.003
Smoking (%) 0.127
Nonsmoker 47.0 38.5
Ex-smoker 28.1 29.5
Current smoker 24.9 32.0
Retinopathy (%) 23.3 40.2 0.001
Erectile dysfunction (%) 26.0 39.3 0.001
Albuminuria (%) 0.001
Normoalbuminuria 65.3 46.6
Microalbuminuria 22.0 23.7
Macroalbuminuria 12.7 29.7
Chronic kidney disease (%) 7.1 10.7 0.144
Use of antihypertensive
medications (%)
27.7 39.3 0.01
Use of ACEI/ARB (%) 80.9 76.2 0.24
Use of lipid-lowering agents (%) 11.2 11.5 0.88
HD  coronary heart disease; other abbreviations as in Table 1.nternational Index of Erectile Function (IIEF)-5 score, re-orted that 70% of patients with type 2 diabetes had ED. The
ssociation between ED and CHD might be due to their many
ommon risk factors. The prevalence of ED was higher among
ubjects with diabetes and silent CHD (angiographically
roven) than those with diabetes alone. In a cross-sectional
tudy, the presence of ED was associated with a 14.8-fold
ncreased risk of CHD and was the most efficient predictor
mong other conventional cardiovascular risk factors (8). In
nother cross-sectional survey, 58% of type 2 diabetic men with
ngiographic evidence of CHD had symptoms of ED before
he development of symptoms of angina (23). These findings
trongly support the notion that ED might be a surrogate
arker for future CHD, although prospective data are lacking.
Approximately 25% of middle-age men are estimated,
ith the Framingham Risk Engine, to develop CHD within
2 years (12). In the present study with a median follow-up
eriod of 4.4 years, Chinese type 2 diabetic men with ED
Figure 1 Cumulative HR of CHD Events Stratified by
ED in 2,306 Chinese Men With Type 2 Diabetes
Other covariates included age, duration of diabetes, systolic blood pressure,
use of antihypertensive agents, low-density lipoprotein cholesterol, estimated
glomerular filtration rate, retinopathy, and albuminuric status at baseline. CHD
 coronary heart disease; ED  erectile dysfunction; HR  hazard ratio.
redictors of New Onset of CHD Events in 2,306hinese Men With Typ 2 Diabetes Withult variat Analysis
Table 3
Predictors of New Onset of CHD Events in 2,306
Chinese Men With Type 2 Diabetes With
Multivariate Analysis
Hazard
Ratio
95% Confidence
Intervals p Value
Age 1.02 1.00–1.04 0.026
Duration of diabetes 1.03 1.00–1.06 0.025
Albuminuria
Normoalbuminuria 1.00
Microalbuminuria 1.28 0.81–2.03 0.30
Macroalbuminuria 2.16 1.37–3.41 0.001
Use of antihypertensive
medications
1.58 1.06–2.35 0.025
Erectile dysfunction 1.58 1.08–2.30 0.018
ther covariates not selected in the final model included SBP, DBP, retinopathy at baseline, eGFR,
se of lipid-lowering agents, and use of ACEI/ARBs.
Abbreviations as in Tables 1 and 2.
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May 27, 2008:2045–50 Erectile Dysfunction and CHD in Diabetesad an annualized CHD event rate of 20/1,000 person-
ears. This represents a 1.6-fold increased risk compared
ith those without ED. Compared with Caucasians, Chi-
ese subjects are known to have lower risk of CHD (24).
owever, in this analysis, Chinese men with diabetes and
D had a CHD event rate comparable to the Caucasian
eneral population (25). Importantly, the risk association
etween ED and new CHD events remained significant
fter adjustment for other confounding factors. Besides,
one of these men had pre-existing cardiovascular diseases,
hus strongly supporting that ED is an early marker of
HD in patients with diabetes. Recently, a guideline on
dentification of cardiovascular diseases in patients with
iabetes was published (26). Our results argue that docu-
entation of ED should be included in the assessment of
ardiovascular risk.
Age, disease duration, and use of antihypertensive med-
cations are important risk factors for CHD, in agreement
ith other reports (6,27–29). In addition, macroalbumin-
ria and ED conferred a 2- and 1.6-fold increased risk of
HD, respectively, independently of these risk factors.
here are strong data showing that endothelial dysfunction
s an important antecedent event in the development of
HD and atherosclerosis (30,31). There is consensus that
lbuminuria might be a marker of endothelial dysfunction
32). Although we did not measure endothelial dysfunction
n these subjects, we have previously reported that Chinese
ype 2 diabetic patients with macroalbuminuria and renal
ysfunction had reduced forearm flow-mediated dilation
ith Doppler ultrasound scan (33).
Taken together, it is conceivable that the penile micro-
irculation might be affected early by metabolic and hemo-
ynamic factors such as hyperglycemia, dyslipidemia, blood
ressure, oxidative stress, and glycation end products. These
ight result in vascular dysfunction giving rise to ED
haracterized by delay in time to maximal erection, reduced
igidity, and decreased ability to sustain an erection. In these
ubjects, similar pathological processes might be expected in
ther parts of the circulation. Impaired endothelium-
ependent and -independent vasodilation are present in
iabetic patients with ED and precede the onset of overt
HD (34,35).
A potential limitation of the current study is the use of
IH criteria during interview to define ED. Sexuality is a
ultural taboo in China. These factors might contribute to
he relatively low frequency of ED as compared with other
tudies (1,2,36). In more recent studies, information on ED
as collected by using the IIEF or IIEF-5 questionnaires,
hich include more objective items, rather than using a
ingle question as in the NIH criteria. Nevertheless, the
atter was regarded as the standard for assessment when the
urrent study was initiated in 1995. Besides, other studies
ave indicated a reasonable correlation between subjective
ssessment by NIH criteria and more detailed assessment
ased on the IIEF-5 (1,37). Although this relatively low
Hercentage of subjects with ED is less likely to give rise to
ype 1 error, it is possible that subjects with more severe
ymptoms of ED were more likely to respond positively and
hus bias the results toward a positive association. Never-
heless, in this prospective analysis, we have collected
onventional risk factors and complications at baseline, and
D remained a significant risk factor after controlling for
hese confounding factors.
There are other limitations to this study. Selection bias
ight be present when patients are recruited from a
ingle center. However, in Hong Kong, most patients
ith chronic diseases such as diabetes are managed in a
ublic hospital where care is heavily subsidized. Although
ariability with single laboratory measurements might
ntroduce errors, our results also demonstrate the benefit
f asking a single question on ED and documenting
linical and biochemical measurement on a single occa-
ion to identify subjects at high risk of CHD. When the
urvey was commenced in 1995, comprehensive cardiac
ssessments were not routinely performed in asymptom-
tic patients. Cardiovascular status was based largely on
edical history or typical symptoms in the presence of
bnormal electrocardiogram or stress test. Thus, it re-
ains possible that patients with silent CHD might
ave been included in the analysis. Another potential
imitation is the limited information on the use of
oncomitant medications, whereby effects from drugs
uch as beta-blockers or diuretics could not be separated
rom those due to other antihypertensive agents in
erms of the relative contribution to ED in affected
ubjects. Although the use of antihypertensive medica-
ions was an independent predictor of new-onset coro-
ary heart disease, impotence remains an independent
redictor on Cox regression analysis. This finding sug-
ested that the association between ED and new-onset
HD is unlikely to be accounted for by the influence of
edications.
onclusions
o our knowledge, this is the first prospective analysis of a
arge cohort of asymptomatic men with type 2 diabetes
howing the risk association between ED and new onset of
HD events. These results strongly suggest that ED is a
urrogate marker for future CHD. Given the preventable
ature of CHD, symptoms of ED should be actively sought
o identify high-risk subjects for comprehensive cardiovas-
ular and metabolic assessments.
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